Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Debuts New Life Sciences HQ in China

NEW YORK (GenomeWeb News) — Agilent Technologies has opened a dual-duty headquarters in Beijing that will house life sciences research and commercial facilities, the company said today.
Agilent CEO Bill Sullivan called the headquarters an “important investment,” saying China is the company’s “second largest and fastest growing market in the world.”
Max Yang, Agilent’s vice president and general manager of its Greater China operations, said the company’s “long-term objective” is to become “further rooted in China and help drive the development of local industries.”
The Life Sciences and Chemical Analysis Center of Excellence and the Agilent Open Lab and Solution Center are situated at the Beijing Want Jing Science Park, the company said, where they will handle R&D, sales, marketing, technical support, and after-sale functions.
The company said the LSCA center will demonstrate Agilent’s bio-analytical-measurement products, and customers will be able to interact with specialists and management.
The OLSC, meantime, will focus on testing and consulting for electronic measurement customers.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.